Ipilimumab 3 mg/kg (n = 11), n (%)
|
|
|
|
|
|
|
|
Pruritus |
55 |
3 (27.3) |
2 (18.2) |
0 |
0 |
0 |
5 (45.5) |
Rash |
55 |
3 (27.3) |
2 (18.2) |
0 |
0 |
0 |
5 (45.5) |
Aspartate aminotransferase increased |
64 |
3 (27.3) |
1 (9.1) |
0 |
0 |
0 |
4 (36.4) |
Constipation |
64 |
1 (9.1) |
3 (27.3) |
0 |
0 |
0 |
4 (36.4) |
Cough |
64 |
3 (27.3) |
1 (9.1) |
0 |
0 |
0 |
4 (36.4) |
Malignant neoplasm progression |
64 |
0 |
0 |
0 |
0 |
4 (36.4) |
4 (36.4) |
Weight decreased |
64 |
2 (18.2) |
2 (18.2) |
0 |
0 |
0 |
4 (36.4) |
Anemia |
73 |
0 |
3 (27.3) |
0 |
0 |
0 |
3 (27.3) |
Decreased appetite |
73 |
2 (18.2) |
1 (9.1) |
0 |
0 |
0 |
3 (27.3) |
Nausea |
73 |
3 (27.3) |
0 |
0 |
0 |
0 |
3 (27.3) |
Asthenia |
82 |
2 (18.2) |
0 |
0 |
0 |
0 |
2 (18.2) |
Blood lactate dehydrogenase |
82 |
0 |
2 (18.2) |
0 |
0 |
0 |
2 (18.2) |
Dizziness |
82 |
2 (18.2) |
0 |
0 |
0 |
0 |
2 (18.2) |
Hypokalemia |
82 |
0 |
0 |
2 (18.2) |
0 |
0 |
2 (18.2) |
Hyponatremia |
82 |
0 |
0 |
1 (9.1) |
1 (9.1) |
0 |
2 (18.2) |
Hypoproteinemia |
82 |
1 (9.1) |
1 (9.1) |
0 |
0 |
0 |
2 (18.2) |
Pain |
82 |
1 (9.1) |
1 (9.1) |
0 |
0 |
0 |
2 (18.2) |
Pyrexia |
82 |
2 (18.2) |
0 |
0 |
0 |
0 |
2 (18.2) |
Vomiting |
82 |
1 (9.1) |
1 (9.1) |
0 |
0 |
0 |
2 (18.2) |
Abdominal pain |
91 |
0 |
1 (9.1) |
0 |
0 |
0 |
1 (9.1) |
Alanine aminotransferase increased |
91 |
0 |
1 (9.1) |
0 |
0 |
0 |
1 (9.1) |
Blood alkaline phosphatase increased |
91 |
1 (9.1) |
0 |
0 |
0 |
0 |
1 (9.1) |
Blood creatinine increased |
91 |
1 (9.1) |
0 |
0 |
0 |
0 |
1 (9.1) |
Chest discomfort |
91 |
1 (9.1) |
0 |
0 |
0 |
0 |
1 (9.1) |
Chest pain |
91 |
0 |
1 (9.1) |
0 |
0 |
0 |
1 (9.1) |
Dreamy state |
91 |
1 (9.1) |
0 |
0 |
0 |
0 |
1 (9.1) |
Electrocardiogram QT prolonged |
91 |
1 (9.1) |
0 |
0 |
0 |
0 |
1 (9.1) |
Emotional disorder |
91 |
0 |
1 (9.1) |
0 |
0 |
0 |
1 (9.1) |
Fatigue |
91 |
1 (9.1) |
0 |
0 |
0 |
0 |
1 (9.1) |
Flushing |
91 |
1 (9.1) |
0 |
0 |
0 |
0 |
1 (9.1) |
Gamma‐glutamyltransferase increased |
91 |
0 |
1 (9.1) |
0 |
0 |
0 |
1 (9.1) |
Gastrointestinal disorder |
91 |
1 (9.1) |
0 |
0 |
0 |
0 |
1 (9.1) |
Hyperkalemia |
91 |
0 |
1 (9.1) |
0 |
0 |
0 |
1 (9.1) |
Hyperthyroidism |
91 |
1 (9.1) |
0 |
0 |
0 |
0 |
1 (9.1) |
Hypothyroidism |
91 |
0 |
1 (9.1) |
0 |
0 |
0 |
1 (9.1) |
Insomnia |
91 |
0 |
1 (9.1) |
0 |
0 |
0 |
1 (9.1) |
Mouth ulceration |
91 |
1 (9.1) |
0 |
0 |
0 |
0 |
1 (9.1) |
Neurotoxicity |
91 |
1 (9.1) |
0 |
0 |
0 |
0 |
1 (9.1) |
Otitis media |
91 |
1 (9.1) |
0 |
0 |
0 |
0 |
1 (9.1) |
Pain in extremity |
91 |
0 |
1 (9.1) |
0 |
0 |
0 |
1 (9.1) |
Pigmentation disorder |
91 |
0 |
1 (9.1) |
0 |
0 |
0 |
1 (9.1) |
Platelet count increased |
91 |
1 (9.1) |
0 |
0 |
0 |
0 |
1 (9.1) |
Pneumonia |
91 |
0 |
1 (9.1) |
0 |
0 |
0 |
1 (9.1) |
Productive cough |
91 |
1 (9.1) |
0 |
0 |
0 |
0 |
1 (9.1) |
Pruritus generalised |
91 |
1 (9.1) |
0 |
0 |
0 |
0 |
1 (9.1) |
Skin disorder |
91 |
0 |
1 (9.1) |
0 |
0 |
0 |
1 (9.1) |
Skin exfoliation |
91 |
0 |
1 (9.1) |
0 |
0 |
0 |
1 (9.1) |
Somnolence |
91 |
1 (9.1) |
0 |
0 |
0 |
0 |
1 (9.1) |
Tachypnoea |
91 |
0 |
1 (9.1) |
0 |
0 |
0 |
1 (9.1) |
Thyroid disorder |
91 |
1 (9.1) |
0 |
0 |
0 |
0 |
1 (9.1) |
Urine abnormality |
91 |
0 |
1 (9.1) |
0 |
0 |
0 |
1 (9.1) |